Roivant Sciences (ROIV) Insider Trading & Ownership $10.68 -0.04 (-0.37%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$10.59 -0.09 (-0.84%) As of 02/21/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Roivant Sciences (NASDAQ:ROIV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$336.90 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$69.83 M Get ROIV Insider Trade Alerts Want to know when executives and insiders are buying or selling Roivant Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROIV Insider Buying and Selling by Quarter Roivant Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/13/2025Eric VenkerCOOSell218,041$10.42$2,271,987.22 2/13/2025Rakhi KumarCAOSell227,500$10.43$2,372,825.00 1/21/2025Eric VenkerCOOSell100,000$11.28$1,128,000.00 1/13/2025Sciences Ltd. RoivantDirectorBuy16,845,010$20.00$336,900,200.00 12/30/2024Eric VenkerCOOSell177,704$11.54$2,050,704.16 12/27/2024Eric VenkerCOOSell176,900$11.82$2,090,958.00 12/26/2024Mayukh SukhatmeCIOSell689,495$12.01$8,280,834.95 12/24/2024Mayukh SukhatmeCIOSell185,946$12.00$2,231,352.00 12/20/2024Eric VenkerCOOSell100,000$11.49$1,149,000.00 12/18/2024Mayukh SukhatmeCIOSell412,584$12.05$4,971,637.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/20/2024Eric VenkerCOOSell100,000$11.32$1,132,000.00 10/21/2024Eric VenkerCOOSell100,000$11.65$1,165,000.00 9/26/2024Financial Lp QvtDirectorSell876,000$11.82$10,354,320.00 9/24/2024Keith S ManchesterDirectorSell368,052$11.62$4,276,764.24 9/23/2024Matthew GlineCEOSell1,983,257$11.79$23,382,600.03 9/23/2024Rakhi KumarCAOSell250,000$11.89$2,972,500.00 (Data available from 1/1/2013 forward) ROIV Insider Trading Activity - Frequently Asked Questions Who is on Roivant Sciences's Insider Roster? The list of insiders at Roivant Sciences includes Eric Venker, Financial Lp Qvt, Global Investors Lp Viking, Keith S Manchester, Matthew Gline, Mayukh Sukhatme, Pharma Technologies Ltd Dexcel, Rakhi Kumar, Richard Pulik, Sciences Ltd. Roivant, Svf Investments (Uk) Ltd, and Vivek Ramaswamy. Learn more on insiders at ROIV. What percentage of Roivant Sciences stock is owned by insiders? 7.90% of Roivant Sciences stock is owned by insiders. Learn more on ROIV's insider holdings. Which Roivant Sciences insiders have been buying company stock? The following insider purchased ROIV shares in the last 24 months: Sciences Ltd. Roivant ($394,900,208.00). How much insider buying is happening at Roivant Sciences? Insiders have purchased a total of 18,371,326 ROIV shares in the last 24 months for a total of $394,900,208.00 bought. Which Roivant Sciences insiders have been selling company stock? The following insiders have sold ROIV shares in the last 24 months: Eric Venker ($37,686,929.75), Financial Lp Qvt ($10,354,320.00), Global Investors Lp Viking ($128,700,000.00), Keith S Manchester ($83,927,227.44), Matthew Gline ($23,382,600.03), Mayukh Sukhatme ($15,483,824.15), Rakhi Kumar ($8,570,541.86), Richard Pulik ($15,448.96), Svf Investments (Uk) Ltd ($222,000,000.00), and Vivek Ramaswamy ($64,950,000.00). How much insider selling is happening at Roivant Sciences? Insiders have sold a total of 57,621,197 Roivant Sciences shares in the last 24 months for a total of $595,070,892.19 sold. Roivant Sciences Key ExecutivesMr. Matthew Gline (Age 40)CEO & Director Compensation: $1.77M1 recent tradesDr. Eric Venker M.D. (Age 37)Pharm.D., President & COO Compensation: $1.28MDr. Mayukh Sukhatme M.D. (Age 48)President, Chief Investment Officer & Director Compensation: $1.72MMr. Richard Pulik (Age 45)Chief Financial Officer Ms. Rakhi Kumar (Age 44)Chief Accounting Officer 2 recent tradesDr. Huafeng Xu Ph.D.Chief Technology OfficerMr. Jo ChenGeneral CounselMs. Kelly GraffHead of PeopleMs. Marianne L. Romeo (Age 56)Head of Global Transactions & Risk Management Mr. Alex GasnerExecutive Vice President of Roivant Health More Insider Trading Tools from MarketBeat Related Companies BNTX Insider Trading TEVA Insider Trading SMMT Insider Trading GMAB Insider Trading ITCI Insider Trading VTRS Insider Trading MRNA Insider Trading PCVX Insider Trading SRPT Insider Trading RVMD Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:ROIV) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ROIV Stock Alerts